Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Explore blue-chip coin candidates beyond BTC/ETH and how they fit into a balanced, long-term strategy with clear evaluation criteria.
24,967 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
As Costco shares hover near $970, analysts outline a constructive path to $1,000 and beyond, driven by membership mom...
Brent crude sits around $74 per barrel as of 8:45 a.m. ET on June 25, 2026, marking a quiet pause after recent volati...
As AI floods daily choices, households face an accuracy of signals that can derail budgets. Edward Enninful’s human-c...
GPIQ has drawn billions with a near-10% yield by selling call options on mega-cap tech. The strategy injects income b...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
When celebrity couples split, the finances can be as dramatic as the headlines. This guide breaks down practical step...
Strategy reveals a potential strategy sell $1.25 billion in Bitcoin to strengthen liquidity and investor confidence a...
A pivotal quarter could set the tone for Micron in 2026. This guide breaks down what happened, why it happened, and h...
When a giant like Verizon leaves the Dow, it can shake investor sentiment and fund flows. This guide explains why suc...
When Rezolve AI announced a stock buyback and reaffirmed guidance, rezolve stock soared higher, signaling renewed inv...
California aims to curb the so-called buy, borrow, die strategy used by ultra-wealthy as part of a broader billionair...